Jing Liu - Clin Pharmacol, Pfizer Inc

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 21 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Assessment of Pharmacokinetic and Pharmacodynamic Interactions Between Zavegepant and Sumatriptan: A Phase 1, Randomized, Placebo-Controlled Study in Healthy Adults

Rajinder Bhardwaj, Mary K Donohue,Jennifer Madonia, Kyle Matschke,Matt S Anderson,Beth Morris,Richard Bertz,Robert Croop,Jing Liu

Headache（2024）

引用0浏览0WOS引用

Pediatric Rare Diseases Development in the Pharmaceutical Industry: An International Consortium for Innovation and Quality in Pharmaceutical Development, Clinical Pharmacology Leadership Group-Pediatrics Working Group, Rare Diseases Subteam Whitepaper Examining the Current Landscape and Recommendations for the Future

Rajesh Krishna,Bernard Sebastien,Solange Corriol-Rohou,S Y Amy Cheung,Jing Liu,Satyendra Suryawanshi

Clinical pharmacology and therapeutics (2024)

引用0浏览0WOS引用

Bioequivalence of Rimegepant, a Small Molecule CGRP Receptor Antagonist, Administered As an Oral Tablet, a Sublingual Orally Disintegrating Tablet, and a Supralingual Orally Disintegrating Tablet: Two Phase 1 Randomized Studies in Healthy Adults

Robert Croop,Rajinder Bhardwaj,Matt S. Anderson,Kyle T. Matschke, Jennifer Hould,Richard Bertz,Jing Liu,Richard B. Lipton

CEPHALALGIAno. 2 (2024)

引用0浏览0WOS引用

A Drug-Drug Interaction Study to Evaluate the Impact of Rimegepant on OCT2- and MATE1-Mediated Transport of Metformin in Healthy Participants

Rajinder Bhardwaj,Beth Morris,Kyle Matschke,Richard Bertz,Robert Croop,Jing Liu

Clinical pharmacology in drug developmentno. 5 (2024): 465-473

引用0浏览0WOS引用

Characterization of Rimegepant Drug-Drug Interactions Using the Cytochrome P450 Probe Drugs, Itraconazole, Rifampin, Fluconazole, and Midazolam

Rajinder Bhardwaj,Beth Morris, Kyle T Matschke,Richard Bertz,Robert Croop,Jing Liu

Headache（2024）

引用0浏览0WOS引用

The Pharmacokinetics, Safety, and Tolerability of Rimegepant 75 mg Are Similar in Elderly and Nonelderly Adults: A Phase 1, Open-Label, Parallel-Group, Single-Dose Study

Rajinder Bhardwaj,Beth Morris,Richard Bertz,Robert Croop,Jing Liu

CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT（2024）

引用2浏览0WOS引用

Population Pharmacokinetic Modeling of Zavegepant, a Calcitonin Gene-Related Peptide Receptor Antagonist, in Healthy Adults and Patients with Migraine

Craig M Comisar, Jose Francis, Jim H Hughes, Rajinder Bhardwaj, Richard Bertz,Jing Liu

CPT pharmacometrics & systems pharmacology (2024)

引用0浏览0WOS引用

Comparative Bioavailability of Single‐dose Zavegepant During and Between Migraine Attacks: A Phase 1, Randomized, Open‐label, Fixed‐sequence, Two‐period Study

Richard J. Bertz, Julie L. Collins,Jennifer Madonia, Rajinder Bhardwaj, Lisa Kamen, Kyle T. Matschke,Jing Liu

Headache The Journal of Head and Face Pain (2024)

引用0浏览0引用

A Randomized, Open-Label, Phase I, Single-Dose Study of Antisense Oligonucleotide, Vupanorsen, in Chinese Adults with Elevated Triglycerides

Xiaojie Wu,Jicheng Yu, Beikang Ge, Jeffrey Wang, Xiaoran Han, Chunye Zhang,Xiaomeng Mao, Hindu Kalluru,Candace Bramson,Steven G. Terra,Jing Liu

DRUGS IN R&Dno. 2 (2024): 253-262

引用0浏览0WOS引用

Reduced Hepatic Impairment Study to Evaluate Pharmacokinetics and Safety of Zavegepant and to Inform Dosing Recommendation for Hepatic Impairment

Rajinder Bhardwaj, Mary K. Donohue,Jennifer Madonia,Beth Morris,Thomas C. Marbury,Kyle T. Matschke,Robert Croop,Richard Bertz,Jing Liu

CTS-CLINICAL AND TRANSLATIONAL SCIENCEno. 7 (2024)

引用0浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn